Hoboken, New Jersey Opens First Cannabis Dispensary
New Jersey gains another cannabis dispensary while Hoboken opens its first store.
In New Jersey, cannabis is legal for both recreational and medical use. The cannabis industry in the state has been slow to develop but a new cannabis dispensary for medical cannabis opened in October 2023 and is the first cannabis dispensary for Hoboken, New Jersey (1).
Known as “The Station”, the medical cannabis dispensary is placed two blocks from the Hoboken train station and is located at River and Newark streets (1). The dispensary hopes to be able to offer recreational cannabis in the future. The Station is owned by Joseph Castelo who also owns the building the dispensary is located in, as well as two other enterprises that reside within the same building (1). The medical cannabis dispensary did not come to fruition overnight, Castelo told The Patch, that it had taken almost 5 years to get The Station up and running due to local and state approvals (1). The Station owner plans to be able to open for recreational used and is waiting on approval from the Hoboken Cannabis Review Board (1).
The decor for the new medical dispensary is inspired by the 1907 Erie Lackawana Train Station not far from the cannabis location (1). It contains antique doors, wood fixtures, and stained glass to bring consumers into a unique and vintage setting. Castelo reported to The Patch (1) that “the railroad is also a metaphor for the cannabis journey.”
On a tour Castello provided on November 20, 2023 he asked (1), “What's your destination?”. He then added, “It could be that you're seeking sleep or calm. Or creativity.”
Before venturing into cannabis, Castelo was a filmmaker. His hope now is for The Station and his other business ventures to benefit one another (1).
Community director of The Station and Sweven, Jawan Robinson told The Patch that, “cannabis customers have come in from all over, particularly from Hoboken, Jersey City, Weehawken, and New York City. They often stop off during their commute,” (1).
In a November 2023 press release, Castelo said (2), “At The Station, we want to help educate patients and consumers, destigmatize cannabis and celebrate the role intentional cannabis consumption can play in nourishing our bodies, minds and relationships while highlighting the positive role cannabis can and will play in the local community and economy.”
References
- Lissner, C. Hoboken’s First Cannabis Dispensary, Founded by Filmmaker, Is Now Open https://patch.com/new-jersey/hoboken/hobokens-first-cannabis-dispensary-founded-filmmaker-now-open (accessed Nov 29, 2023).
- Terrapin Care Station, Hoboken’s First Cannabis Dispensary, is Now Open https://www.businesswire.com/news/home/20231101667264/en/Terrapin-Care-Station-Hoboken%E2%80%99s-First-Cannabis-Dispensary-Is-Now-Open (accessed Nov 29, 2023).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
